Literature DB >> 22527713

Regulation of Parkin E3 ubiquitin ligase activity.

Helen Walden1, R Julio Martinez-Torres.   

Abstract

Parkin is an E3 ubiquitin ligase mutated in autosomal recessive juvenile Parkinson's disease. In addition, it is a putative tumour suppressor, and has roles outside its enzymatic activity. It is critical for mitochondrial clearance through mitophagy, and is an essential protein in most eukaryotes. As such, it is a tightly controlled protein, regulated through an array of external interactions with multiple proteins, posttranslational modifications including phosphorylation and S-nitrosylation, and self-regulation through internal associations. In this review, we highlight some of the recent studies into Parkin regulation and discuss future challenges for gaining a full molecular understanding of the regulation of Parkin E3 ligase activity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22527713     DOI: 10.1007/s00018-012-0978-5

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  141 in total

1.  Parkin expression in the adult mouse brain.

Authors:  C C Stichel; M Augustin; K Kühn; X R Zhu; P Engels; C Ullmer; H Lübbert
Journal:  Eur J Neurosci       Date:  2000-12       Impact factor: 3.386

2.  Proteasomal inhibition causes the formation of protein aggregates containing a wide range of proteins, including nitrated proteins.

Authors:  Dong-Hoon Hyun; MoonHee Lee; Barry Halliwell; Peter Jenner
Journal:  J Neurochem       Date:  2003-07       Impact factor: 5.372

3.  Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity.

Authors:  Dongdong Yao; Zezong Gu; Tomohiro Nakamura; Zhong-Qing Shi; Yuliang Ma; Benjamin Gaston; Lisa A Palmer; Edward M Rockenstein; Zhuohua Zhang; Eliezer Masliah; Takashi Uehara; Stuart A Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-13       Impact factor: 11.205

4.  Parkin ubiquitinates Drp1 for proteasome-dependent degradation: implication of dysregulated mitochondrial dynamics in Parkinson disease.

Authors:  Hongxia Wang; Pingping Song; Lei Du; Weili Tian; Wen Yue; Min Liu; Dengwen Li; Bin Wang; Yushan Zhu; Cheng Cao; Jun Zhou; Quan Chen
Journal:  J Biol Chem       Date:  2011-02-03       Impact factor: 5.157

5.  Autoregulation of Parkin activity through its ubiquitin-like domain.

Authors:  Viduth K Chaugule; Lynn Burchell; Kathryn R Barber; Ateesh Sidhu; Simon J Leslie; Gary S Shaw; Helen Walden
Journal:  EMBO J       Date:  2011-06-21       Impact factor: 11.598

6.  PINK1 controls mitochondrial localization of Parkin through direct phosphorylation.

Authors:  Yongsung Kim; Jeehye Park; Sunhong Kim; Saera Song; Seok-Kyu Kwon; Sang-Hee Lee; Tohru Kitada; Jin-Man Kim; Jongkyeong Chung
Journal:  Biochem Biophys Res Commun       Date:  2008-10-26       Impact factor: 3.575

7.  PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1.

Authors:  Sven Geisler; Kira M Holmström; Diana Skujat; Fabienne C Fiesel; Oliver C Rothfuss; Philipp J Kahle; Wolfdieter Springer
Journal:  Nat Cell Biol       Date:  2010-01-24       Impact factor: 28.824

8.  Ubiquitinylation of α-synuclein by carboxyl terminus Hsp70-interacting protein (CHIP) is regulated by Bcl-2-associated athanogene 5 (BAG5).

Authors:  Lorraine V Kalia; Suneil K Kalia; Hien Chau; Andres M Lozano; Bradley T Hyman; Pamela J McLean
Journal:  PLoS One       Date:  2011-02-16       Impact factor: 3.240

9.  Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration.

Authors:  Suzana Gispert; Filomena Ricciardi; Alexander Kurz; Mekhman Azizov; Hans-Hermann Hoepken; Dorothea Becker; Wolfgang Voos; Kristina Leuner; Walter E Müller; Alexei P Kudin; Wolfram S Kunz; Annabelle Zimmermann; Jochen Roeper; Dirk Wenzel; Marina Jendrach; Moisés García-Arencíbia; Javier Fernández-Ruiz; Leslie Huber; Hermann Rohrer; Miguel Barrera; Andreas S Reichert; Udo Rüb; Amy Chen; Robert L Nussbaum; Georg Auburger
Journal:  PLoS One       Date:  2009-06-03       Impact factor: 3.240

10.  DNA damage induces nuclear translocation of parkin.

Authors:  Shyan-Yuan Kao
Journal:  J Biomed Sci       Date:  2009-07-17       Impact factor: 8.410

View more
  37 in total

1.  Structural and Functional Impact of Parkinson Disease-Associated Mutations in the E3 Ubiquitin Ligase Parkin.

Authors:  Fabienne C Fiesel; Thomas R Caulfield; Elisabeth L Moussaud-Lamodière; Kotaro Ogaki; Daniel F A R Dourado; Samuel C Flores; Owen A Ross; Wolfdieter Springer
Journal:  Hum Mutat       Date:  2015-06-03       Impact factor: 4.878

Review 2.  Promoter DNA hypermethylation - Implications for Alzheimer's disease.

Authors:  Yiyuan Liu; Minghui Wang; Edoardo M Marcora; Bin Zhang; Alison M Goate
Journal:  Neurosci Lett       Date:  2019-07-24       Impact factor: 3.046

Review 3.  New insights into ubiquitin E3 ligase mechanism.

Authors:  Christopher E Berndsen; Cynthia Wolberger
Journal:  Nat Struct Mol Biol       Date:  2014-04       Impact factor: 15.369

Review 4.  Keeping the immune system in check: a role for mitophagy.

Authors:  Michael Lazarou
Journal:  Immunol Cell Biol       Date:  2014-09-30       Impact factor: 5.126

5.  DUBs counteract parkin for efficient mitophagy.

Authors:  Ivan Dikic; Anja Bremm
Journal:  EMBO J       Date:  2014-10-01       Impact factor: 11.598

6.  Parkin Regulates Mitosis and Genomic Stability through Cdc20/Cdh1.

Authors:  Seung Baek Lee; Jung Jin Kim; Hyun-Ja Nam; Bowen Gao; Ping Yin; Bo Qin; Sang-Yeop Yi; Hyoungjun Ham; Debra Evans; Sun-Hyun Kim; Jun Zhang; Min Deng; Tongzheng Liu; Haoxing Zhang; Daniel D Billadeau; Liewei Wang; Emilie Giaime; Jie Shen; Yuan-Ping Pang; Jin Jen; Jan M van Deursen; Zhenkun Lou
Journal:  Mol Cell       Date:  2015-09-17       Impact factor: 17.970

Review 7.  How Studies of the Serotonin System in Macaque Models of Menopause Relate to Alzheimer's Disease1.

Authors:  Cynthia L Bethea; Arubala P Reddy; Fernanda Lima Christian
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 8.  Posttranslational modification and quality control.

Authors:  Xuejun Wang; J Scott Pattison; Huabo Su
Journal:  Circ Res       Date:  2013-01-18       Impact factor: 17.367

Review 9.  Targeting Pink1-Parkin-mediated mitophagy for treating liver injury.

Authors:  Jessica A Williams; Wen-Xing Ding
Journal:  Pharmacol Res       Date:  2015-10-24       Impact factor: 7.658

Review 10.  An emerging role of PARK2 in cancer.

Authors:  Liang Xu; De-chen Lin; Dong Yin; H Phillip Koeffler
Journal:  J Mol Med (Berl)       Date:  2013-12-03       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.